Navigation Links
CeQur SA Appoints Eric Milledge Chairman of the Board of Directors
Date:10/6/2009

maintaining glycemic control and managing multiple, daily insulin injections is a continuous challenge. I'm pleased to be part of CeQur's mission to make it easier for people with type 2 diabetes to stay in control of their disease."

About CeQur SA

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company's lead product candidate is the CeQur(TM) Insulin Infuser, a novel, wearable insulin delivery device that provides freedom from multiple daily injections by offering up to three days of consistent, basal insulin delivery along with bolus insulin at the push of a button. More information can be found at www.cequrcorp.com.

SOURCE CeQur SA


'/>"/>
SOURCE CeQur SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...
(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Americas Registered Nurses Applaud New Institute of Medicine H1N1 Swine Flu Safety Recommendations and Call on CDC to Maintain Stringent Safety Gui 56316 1Americas Registered Nurses Applaud New Institute of Medicine H1N1 Swine Flu Safety Recommendations and Call on CDC to Maintain Stringent Safety Gui 56316 2Single Parents May Do as Well as Two 3A Study 56314 1Single Parents May Do as Well as Two 3A Study 56314 2TrueShred Earns Industrys Highest Security Certification 56311 1
... sustained levels of drug reported after one treatmentLOUISVILLE, ... held biotechnology company developing medicines for the treatment ... it successfully completed its Phase I ASaP (Assessment ... with Neovascular Age-Related Macular Degeneration) clinical trial for ...
... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...
Other Medicine Technology:Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 2Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 3Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
(Date:12/15/2009)... Austrian researchers have successfully developed a new electrophoretic ... in the blood. The technique, using SARCOSYL-PAGE, ... not alter the performance characteristics of SDS-PAGE for ... funded by a grant from the World Anti-Doping ... Drug Testing and Analysis published by ...
(Date:12/15/2009)... Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies ... resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on ... Votes ... Non-, Matter ... For Against ...
(Date:12/15/2009)... of America and the Saint Thomas, Lupus Trust ... son of the legendary John Lennon, and James Scott ... raise funds for research on the disease lupus. From ... proceeds from downloading "LUCY" at iTunes will be donated ... Saint Thomas, Lupus Trust in Great Britain. ,, Both ...
(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a leading ... States, today announced that,it will host a conference call ... management to review the company,s third quarter results. ... conference call will be held on Wednesday, October,31, 2007 ...
... Injustice, Will Challenge,Corporate-Backed Proponents of "Health Courts", ... Nance, co-author of the groundbreaking new report on ... featured speakers at a,patient safety forum in Cheyenne, ... the merits and weaknesses of the health courts ...
... http://www.medikeeper.com ), a leading provider of technology solutions ... Series A investment round,led by Hawaii-based venture capital ... by a team of entrepreneurs and medical,professionals with ... accessible online. Beginning with its flagship Personal Health ...
... New T-Shirt Design Marks 2007 Race in San Diego, ... Komen San,Diego Race for the Cure(R) will be held in ... than three weeks until the Race, participants still,have two final ... http://www.komensandiego.org until Monday, October 22 or visit,Roadrunner Sports at ...
... Massachusetts,is not a model for California health reform, according ... to buy private health coverage.,Coverage in Massachusetts is already ... not capped or regulated, have indicated rates,will increase again ... Massachusetts law, which provides an,overview of the cost and ...
... the drugs are used with certain painkillers, study finds ... called selective serotonin reuptake inhibitors (SSRIs), which include Celexa, ... gastrointestinal bleeding, and the threat is more than six ... medications at the same time as SSRIs, a new ...
Other Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 2Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 3Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 2Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 3Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 4Health News:Antidepressants Boost GI Bleeding Risk 2
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat...
... Topical Anesthetic, ,Designed for adolescent ... incorporates an additional lumen and injection ... anesthetic above and below the cuff., ... designs which allow for CO2 monitoring, ...
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
SHERIDAN PREFORMED Endotracheal Tubes are designed to conveniently position the anesthesia circuit out of the surgical field for oral and maxillofacial procedures....
Medicine Products: